Matches in Wikidata for { <http://www.wikidata.org/entity/Q62110700> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q62110700 description "clinical trial" @default.
- Q62110700 description "ensayu clínicu" @default.
- Q62110700 description "klinisch onderzoek" @default.
- Q62110700 description "клінічне випробування" @default.
- Q62110700 description "临床试验" @default.
- Q62110700 name "Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme" @default.
- Q62110700 type Item @default.
- Q62110700 label "Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme" @default.
- Q62110700 prefLabel "Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme" @default.
- Q62110700 P1050 Q62110700-033552EE-E15C-41F8-9CD3-E17C07B0C1AF @default.
- Q62110700 P1132 Q62110700-75FAEF2D-B09A-467F-B28C-CA5363EAED02 @default.
- Q62110700 P1476 Q62110700-2C7A4438-FD76-4D97-90CA-49A237731B4E @default.
- Q62110700 P17 Q62110700-AB820337-8C02-461F-ADC1-0B37BA4D2901 @default.
- Q62110700 P3098 Q62110700-4C749B66-76EC-4F49-AF67-16A3335964F6 @default.
- Q62110700 P31 Q62110700-9E2723C3-B433-4A53-89AA-D85E61862251 @default.
- Q62110700 P4844 Q62110700-527BBE8C-78C0-4D0A-AC9B-216DC1EDC70D @default.
- Q62110700 P580 Q62110700-5B42EA6F-5F34-4399-B41C-D5A94309368D @default.
- Q62110700 P582 Q62110700-C7414B8B-0D97-43F7-9D82-271D5302C80F @default.
- Q62110700 P6099 Q62110700-4FCE060D-6BAE-4574-B1F9-E4E0B2390A75 @default.
- Q62110700 P6099 Q62110700-F8ABFEA6-3A60-40AC-A729-3E36CA242431 @default.
- Q62110700 P6153 Q62110700-1F16D5F0-508A-4D43-AEB5-EB589ADAB3F6 @default.
- Q62110700 P6153 Q62110700-4901EAB2-F1D4-4A03-AB7F-527E8D6C6AC0 @default.
- Q62110700 P6153 Q62110700-6B9D0E2E-E325-4653-BF84-EC4CCF5AF6EE @default.
- Q62110700 P6153 Q62110700-9996004E-CEA8-47DC-854B-6ADE51E19791 @default.
- Q62110700 P6153 Q62110700-B792642F-5B95-485C-ACF9-374CF43BE5CF @default.
- Q62110700 P6153 Q62110700-CA5EF041-FE21-4C95-800A-ECA88B93F06D @default.
- Q62110700 P6153 Q62110700-CD6E743F-E35B-4F0C-A869-DEC099E41ABF @default.
- Q62110700 P8005 Q62110700-F2CEDC94-E3BC-4269-9CA1-F6E594C881E8 @default.
- Q62110700 P8363 Q62110700-5C7F07FF-210F-4487-9451-270D6163BFD9 @default.
- Q62110700 P859 Q62110700-6B1BDA75-128A-4A61-8FF9-FDD07BDF48C4 @default.
- Q62110700 P1050 Q609503 @default.
- Q62110700 P1132 "+112" @default.
- Q62110700 P1476 "A Safety Run-in/Randomized Phase II Trial of EMD 121974 in Conjunction With Concomitant and Adjuvant Temozolomide With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme" @default.
- Q62110700 P17 Q30 @default.
- Q62110700 P3098 "NCT00085254" @default.
- Q62110700 P31 Q30612 @default.
- Q62110700 P4844 Q425088 @default.
- Q62110700 P580 "2005-04-01T00:00:00Z" @default.
- Q62110700 P582 "2012-11-01T00:00:00Z" @default.
- Q62110700 P6099 Q42824440 @default.
- Q62110700 P6099 Q5452194 @default.
- Q62110700 P6153 Q126412 @default.
- Q62110700 P6153 Q1472663 @default.
- Q62110700 P6153 Q193727 @default.
- Q62110700 P6153 Q392667 @default.
- Q62110700 P6153 Q4117596 @default.
- Q62110700 P6153 Q49117 @default.
- Q62110700 P6153 Q621043 @default.
- Q62110700 P8005 Q76651189 @default.
- Q62110700 P8363 Q78089383 @default.
- Q62110700 P859 Q664846 @default.